Recursion Pharmaceuticals is trading at $3.14 (5.1% down) today amid a lack of fresh, company-specific news or major announcements directly tied to the move.
- The drop follows recent volatility and prior weakness after its May 6, 2026, Q1 earnings report, where a revenue miss drove shares lower.
- No new earnings, regulatory, or pipeline events have been reported to explain today's specific decline.